Six types of drugs are covered in our dataset for psoriasis treatment, including MTX, topical corticosteroid (TCS), acitretin, tumor necrosis factor alpha (TNF-α) inhibitors, interleukin-17 (IL-17) inhibitors, and interleukin-23 (IL-23) inhibitors. Here, IL17A is linked to psoriasis.